254 related articles for article (PubMed ID: 35305717)
1. Noncoding RNAs as novel immunotherapeutic tools against cancer.
Kaur M; Kaur B; Konar M; Sharma S
Adv Protein Chem Struct Biol; 2022; 129():135-161. PubMed ID: 35305717
[TBL] [Abstract][Full Text] [Related]
2. The regulatory role of long non- coding RNAs as a novel controller of immune response against cancer cells.
Mofed D; Omran JI; Sabet S; Baiomy AA; Emara M; Salem TZ
Mol Biol Rep; 2022 Dec; 49(12):11775-11793. PubMed ID: 36207500
[TBL] [Abstract][Full Text] [Related]
3. Noncoding RNAs as potential mediators of resistance to cancer immunotherapy.
Vishnubalaji R; Shaath H; Elango R; Alajez NM
Semin Cancer Biol; 2020 Oct; 65():65-79. PubMed ID: 31733291
[TBL] [Abstract][Full Text] [Related]
4. Viral non-coding RNAs: Stealth strategies in the tug-of-war between humans and herpesviruses.
Tagawa T; Serquiña A; Kook I; Ziegelbauer J
Semin Cell Dev Biol; 2021 Mar; 111():135-147. PubMed ID: 32631785
[TBL] [Abstract][Full Text] [Related]
5. Noncoding RNAs in cancer immunity: functions, regulatory mechanisms, and clinical application.
Zhang L; Xu X; Su X
Mol Cancer; 2020 Mar; 19(1):48. PubMed ID: 32122338
[TBL] [Abstract][Full Text] [Related]
6. The Role of Long Non-Coding RNAs in the Tumor Immune Microenvironment.
Guo Y; Xie Y; Luo Y
Front Immunol; 2022; 13():851004. PubMed ID: 35222443
[TBL] [Abstract][Full Text] [Related]
7. Noncoding RNAs in cancer and cancer stem cells.
Huang T; Alvarez A; Hu B; Cheng SY
Chin J Cancer; 2013 Nov; 32(11):582-93. PubMed ID: 24206916
[TBL] [Abstract][Full Text] [Related]
8. Noncoding RNAs: New Players in Cancers.
Chen X; Fan S; Song E
Adv Exp Med Biol; 2016; 927():1-47. PubMed ID: 27376730
[TBL] [Abstract][Full Text] [Related]
9. Noncoding RNAs in breast cancer.
Lo PK; Wolfson B; Zhou X; Duru N; Gernapudi R; Zhou Q
Brief Funct Genomics; 2016 May; 15(3):200-21. PubMed ID: 26685283
[TBL] [Abstract][Full Text] [Related]
10. PD-1/PD-L1 axis regulation in cancer therapy: The role of long non-coding RNAs and microRNAs.
Ashrafizadeh M; Zarrabi A; Hushmandi K; Zarrin V; Moghadam ER; Zabolian A; Tavakol S; Samarghandian S; Najafi M
Life Sci; 2020 Sep; 256():117899. PubMed ID: 32504749
[TBL] [Abstract][Full Text] [Related]
11. miRNAs and lncRNAs as Novel Therapeutic Targets to Improve Cancer Immunotherapy.
Di Martino MT; Riillo C; Scionti F; Grillone K; Polerà N; Caracciolo D; Arbitrio M; Tagliaferri P; Tassone P
Cancers (Basel); 2021 Mar; 13(7):. PubMed ID: 33808190
[TBL] [Abstract][Full Text] [Related]
12. Phytochemicals mediated modulation of microRNAs and long non-coding RNAs in cancer prevention and therapy.
Ruiz-Manriquez LM; Estrada-Meza C; Benavides-Aguilar JA; Ledesma-Pacheco SJ; Torres-Copado A; Serrano-Cano FI; Bandyopadhyay A; Pathak S; Chakraborty S; Srivastava A; Sharma A; Paul S
Phytother Res; 2022 Feb; 36(2):705-729. PubMed ID: 34932245
[TBL] [Abstract][Full Text] [Related]
13. lncRNAs and microRNAs with a role in cancer development.
Liz J; Esteller M
Biochim Biophys Acta; 2016 Jan; 1859(1):169-76. PubMed ID: 26149773
[TBL] [Abstract][Full Text] [Related]
14. Relationship Between Noncoding RNA Dysregulation and Epigenetic Mechanisms in Cancer.
Suzuki H; Maruyama R; Yamamoto E; Niinuma T; Kai M
Adv Exp Med Biol; 2016; 927():109-35. PubMed ID: 27376733
[TBL] [Abstract][Full Text] [Related]
15. Non-coding RNAs and macrophage interaction in tumor progression.
Entezari M; Sadrkhanloo M; Rashidi M; Asnaf SE; Taheriazam A; Hashemi M; Ashrafizadeh M; Zarrabi A; Rabiee N; Hushmandi K; Mirzaei S; Sethi G
Crit Rev Oncol Hematol; 2022 May; 173():103680. PubMed ID: 35405273
[TBL] [Abstract][Full Text] [Related]
16. Interplay Between Long Noncoding RNAs and MicroRNAs in Cancer.
Russo F; Fiscon G; Conte F; Rizzo M; Paci P; Pellegrini M
Methods Mol Biol; 2018; 1819():75-92. PubMed ID: 30421400
[TBL] [Abstract][Full Text] [Related]
17. Functions of non-coding RNAs in regulating cancer drug targets.
Chai B; Ma Z; Wang X; Xu L; Li Y
Acta Biochim Biophys Sin (Shanghai); 2022 Mar; 54(3):279-291. PubMed ID: 35538038
[TBL] [Abstract][Full Text] [Related]
18. Long Non-Coding RNAs (lncRNAs) in Response and Resistance to Cancer Immunosurveillance and Immunotherapy.
Eptaminitaki GC; Wolff N; Stellas D; Sifakis K; Baritaki S
Cells; 2021 Nov; 10(12):. PubMed ID: 34943820
[TBL] [Abstract][Full Text] [Related]
19. Noncoding RNAs as an emerging resistance mechanism to immunotherapies in cancer: basic evidence and therapeutic implications.
Wang M; Yu F; Li P
Front Immunol; 2023; 14():1268745. PubMed ID: 37767098
[TBL] [Abstract][Full Text] [Related]
20. Dysregulation of non-coding RNAs in gastric cancer.
Yang Q; Zhang RW; Sui PC; He HT; Ding L
World J Gastroenterol; 2015 Oct; 21(39):10956-81. PubMed ID: 26494954
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
